| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_149ba0769c6206c60565d0e6ddd0a3e0 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B90-361
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B90-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2018-00577
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2090-3941
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2017-00061
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2090-373
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2090-376
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B2018-00982
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B1-0005 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-0071
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B1-0638
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-0036
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-0084
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B5-4836
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B1-043
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61B18-20 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B1-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B18-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61B1-04 |
| filingDate |
2019-01-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c6b6b33b9916d5bcf9a8cfe45c3375c1 |
| publicationDate |
2019-05-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2019150718-A1 |
| titleOfInvention |
Method for visualizing tissue with an icg dye composition during ablation procedures |
| abstract |
A system is provided for identifying the sufficiency of lesions formed during a tissue ablation procedure. The system and method include administering an ICG composition to the patient and forming one or more lesions at a surgical site. The method further includes applying energy of a type and in an amount sufficient to cause ICG in the patient to fluoresce. An image of the tissue and lesion at the surgical site is obtained while the ICG fluoresces. The lesion is distinguished from surrounding de novo tissue based on areas of fluorescence to allow a user to evaluate the quality of the lesion. |
| priorityDate |
2014-04-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |